{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:17:15Z","timestamp":1762917435855},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1097\/rhu.0b013e31821c7ef6","type":"journal-article","created":{"date-parts":[[2012,12,17]],"date-time":"2012-12-17T17:57:41Z","timestamp":1355767061000},"page":"211-213","source":"Crossref","is-referenced-by-count":5,"title":["Reversal of Transfusion Dependence by Tumor Necrosis Factor Inhibitor Treatment in a Patient With Concurrent Rheumatoid Arthritis and Primary Myelofibrosis"],"prefix":"10.1097","volume":"17","author":[{"given":"Anderson","family":"Ong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Quach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Leech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210207","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1182\/blood.V74.1.130.130","article-title":"Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice.","volume":"74","author":"Johnson","year":"1989","journal-title":"Blood"},{"key":"R2-11-20210207","first-page":"2986","article-title":"Phase 1 study of recombinant tumor necrosis factor in cancer patients.","volume":"47","author":"Blick","year":"1987","journal-title":"Cancer Res"},{"key":"R3-11-20210207","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1182\/blood-2002-01-0136","article-title":"Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy.","volume":"100","author":"Papadaki","year":"2002","journal-title":"Blood"},{"key":"R4-11-20210207","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1182\/blood.V99.5.1610","article-title":"Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect.","volume":"99","author":"Papadaki","year":"2002","journal-title":"Blood"},{"key":"R5-11-20210207","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1182\/blood.V99.6.2252","article-title":"Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: results of a pilot study.","volume":"99","author":"Steensma","year":"2002","journal-title":"Blood"},{"key":"R6-11-20210207","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/sj.leu.2402356","article-title":"Soluble TNF receptor fusion protein (etanercept) for the treatment of myelodysplastic syndrome: a pilot study.","volume":"16","author":"Deeg","year":"2002","journal-title":"Leukemia"},{"key":"R7-11-20210207","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00280-002-0479-6","article-title":"Recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein Enbrel in patients with refractory hematologic malignancies.","volume":"50","author":"Tsimberidou","year":"2002","journal-title":"Cancer Chemother Pharmacol"},{"key":"R8-11-20210207","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF01816434","article-title":"Effects of desferrioxamine therapy on chronic disease anemia associated with rheumatoid arthritis.","volume":"16","author":"Salvarani","year":"1996","journal-title":"Rheumatol Int"},{"key":"R9-11-20210207","doi-asserted-by":"crossref","first-page":"L24","DOI":"10.1152\/ajplung.00428.2003","article-title":"TNF, IFN-gamma, and endotoxin increase expression of DMT1 in bronchial epithelial cells.","volume":"289","author":"Wang","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R10-11-20210207","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1046\/j.1365-2362.1998.00323.x","article-title":"Regulation of iron metabolism in the acute-phase response: interferon-gamma and tumor necrosis factor induce hypoferraemia, ferritin production and a decrease in circulating transferrin receptors in cancer patients.","volume":"28","author":"Feelders","year":"1998","journal-title":"Eur J Clin Invest"},{"key":"R11-11-20210207","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1182\/blood-2003-03-0672","article-title":"Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation.","volume":"102","author":"Ganz","year":"2003","journal-title":"Blood"},{"key":"R12-11-20210207","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1182\/blood.V85.4.989.bloodjournal854989","article-title":"Tumor necrosis factor-alpha directly inhibits human erythropoiesis in vitro: role of pp55 and p75 TNF receptors.","volume":"85","author":"Rusten","year":"1995","journal-title":"Blood"},{"key":"R13-11-20210207","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1182\/blood.V79.8.1987.1987","article-title":"Effect of inflammatory cytokines on hypoxia-induced erythropoietin production.","volume":"79","author":"Faquin","year":"1992","journal-title":"Blood"},{"key":"R14-11-20210207","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semarthrit.2008.08.002","article-title":"Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large multicenter, double-blind, randomized clinical trials review.","volume":"39","author":"Doyle","year":"2009","journal-title":"Semin Arthritis Rheum"},{"key":"R15-11-20210207","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/rheumatology\/36.9.950","article-title":"Anemia of chronic disease in rheumatoid arthritis: in vivo effects of tumor necrosis factor alpha blockade.","volume":"36","author":"Davis","year":"1997","journal-title":"Br J Rheumatol"}],"container-title":["JCR: Journal of Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RHU.0b013e31821c7ef6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:55:53Z","timestamp":1620971753000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00124743-201106000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/rhu.0b013e31821c7ef6","relation":{},"ISSN":["1076-1608"],"issn-type":[{"value":"1076-1608","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}